Simon Van Herck
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune cells in cancer
- Immune Response and Inflammation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 16
- Immunotherapy and Immune Responses 11
- Immune Response and Inflammation 10
-
- RNA Interference and Gene Delivery 9
- Co-authors
- Bruno G. De Geest (26 shared papers)Li Tang (3 shared papers)Bing Feng (1 shared paper)Lutz Nuhn (15 shared papers)Kim Deswarte (11 shared papers)Bart N. Lambrecht (11 shared papers)Sunil A. David (7 shared papers)Stefan Lienenklaus (7 shared papers)
- Journals
- Angewandte Chemie International Edition (3 papers)Journal of the American Chemical Society (2 papers)International Journal of Pharmaceutics (2 papers)Advanced Healthcare Materials (2 papers)Advanced Therapeutics (2 papers)
- Partner nations
- BelgiumGermanyUnited States
In The Last Decade
Simon Van Herck
32 papers receiving 935 citations
Peers
Comparison fields: 5 of 89
- Immunology 402
- Biomaterials 234
- Pharmaceutical Science 60
- Molecular Medicine 41
- Biomedical Engineering 307
Countries citing papers authored by Simon Van Herck
This map shows the geographic impact of Simon Van Herck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Van Herck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Van Herck more than expected).
Fields of papers citing papers by Simon Van Herck
This network shows the impact of papers produced by Simon Van Herck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Van Herck. The network helps show where Simon Van Herck may publish in the future.
Co-authors
The 25 scholars most cited alongside Simon Van Herck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 136 | |
| 2 | 2018 | 92 | |
| 3 | 2020 | 84 | |
| 4 | 2018 | 58 | |
| 5 | 2021 | 56 | |
| 6 | 2019 | 55 | |
| 7 | 2018 | 51 | |
| 8 | 2020 | 50 | |
| 9 | 2019 | 47 | |
| 10 | 2021 | 36 | |
| 11 | 2018 | 34 | |
| 12 | 2021 | 30 | |
| 13 | 2020 | 24 | |
| 14 | 2017 | 20 | |
| 15 | 2018 | 19 | |
| 16 | 2022 | 16 | |
| 17 | 2017 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2017 | 13 |
About Simon Van Herck
Simon Van Herck is a scholar working on Immunology, Molecular Biology, Biomaterials, Organic Chemistry and Biomedical Engineering, having authored 33 papers that have together received 941 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Nanoparticle-Based Drug Delivery (10 papers), Immune Response and Inflammation (10 papers), RNA Interference and Gene Delivery (9 papers), Advanced Polymer Synthesis and Characterization (7 papers), Nanoplatforms for cancer theranostics (5 papers), Hydrogels: synthesis, properties, applications (4 papers) and Polymer Surface Interaction Studies (3 papers). The work is most often cited by research in Immunology (402 citations), Biomaterials (234 citations), Pharmaceutical Science (60 citations), Molecular Medicine (41 citations) and Biomedical Engineering (307 citations). Simon Van Herck has collaborated with scholars based in Belgium, Germany and United States. Frequent co-authors include Bruno G. De Geest, Li Tang, Bing Feng, Lutz Nuhn, Kim Deswarte, Bart N. Lambrecht, Sunil A. David, Stefan Lienenklaus, Niek N. Sanders and Zifu Zhong. Their work appears in journals such as Angewandte Chemie International Edition, Journal of the American Chemical Society, International Journal of Pharmaceutics, Advanced Healthcare Materials and Advanced Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.